Jocil

Which are the latest news on Jocil?

Why is Jocil Ltd falling/rising?

As of 19-Jun, Jocil Ltd's stock price is at 152.16, down 0.55% due to underperformance against its sector. Despite a 13.82% gain over the past month, it lags behind the Sensex, and short-term weakness is indicated by its position relative to moving averages.

As of 19-Jun, Jocil Ltd's stock price is currently at 152.16, reflecting a decrease of 0.84 points or 0.55%. This decline can be attributed to its performance today, where it underperformed the sector by 1.55%. Although the stock has shown positive returns over the past month, with a gain of 13.82%, it has not kept pace with the benchmark Sensex, which rose by 1.67% during the same period. Additionally, while the stock is trading higher than its 20-day, 50-day, 100-day, and 200-day moving averages, it is lower than its 5-day moving average, indicating a short-term weakness. Overall, the combination of underperformance against the sector and the recent price drop contributes to the current decline in Jocil Ltd's stock price.

How big is Jocil?

As of 10th June, Jocil Ltd has a market capitalization of 137.00 Cr, with recent net sales of 1043.70 Cr and a net profit of 8.29 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Jocil Ltd has a market capitalization of 137.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 1043.70 Cr, while the sum of Net Profit for the same period is 8.29 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025, with Shareholder's Funds amounting to 206.08 Cr and Total Assets totaling 287.67 Cr.

Who are in the management team of Jocil?

The management team of Jocil includes J Murali Mohan as Managing Director, P Narendranath Chowdary as Chairman, and several non-executive directors, alongside K Raghuram as Chief Finance Officer. This diverse team provides governance and strategic direction for the company.

The management team of Jocil includes the following individuals:<BR><BR>1. **J Murali Mohan** - Managing Director<BR>2. **P Narendranath Chowdary** - Chairman (Non-Executive)<BR>3. **Mullapudi Thimmaraja** - Non-Executive & Non-Independent Director<BR>4. **V S Raju** - Non-Executive & Independent Director<BR>5. **K Srinivasa Rao** - Non-Executive & Non-Independent Director<BR>6. **Subbarao V Tipirneni** - Non-Executive & Independent Director<BR>7. **M Mrutyumjaya Prasad** - Non-Executive & Non-Independent Director<BR>8. **Manjulata Dasari** - Non-Executive & Independent Director<BR>9. **K Rama Seshayya** - Non-Executive & Independent Director<BR>10. **K Raghuram** - Chief Finance Officer & Company Secretary<BR>11. **P A Chowdary** - Additional Independent Director<BR><BR>This team brings a mix of executive and non-executive roles to the company, contributing to its governance and strategic direction.

Who are the peers of the Jocil?

Jocil's peers include Mahickra Chem., Arvee Laborat., Indian Phosphate, and others, with varying management and growth risks. Mahickra Chem. has the highest 1-year return at 88.37%, while Jocil's return is -10.23%.

Peers: The peers of Jocil are Mahickra Chem., Arvee Laborat., Indian Phosphate, Vital Chemtech, Hindcon Chemical, Par Drugs & Che., Paragon Fine, Ushanti Colour, Indian Emuls, and Nilachal Carbo.<BR><BR>Quality Snapshot: Excellent management risk is observed at Indian Phosphate, Par Drugs & Che., and Paragon Fine, while Average management risk is found at Jocil, Mahickra Chem., Hindcon Chemical, and the rest. Below Average management risk is noted at Arvee Laborat., Vital Chemtech, Ushanti Colour, and Indian Emuls. Growth ratings show Excellent growth at Indian Emuls, while Average growth is seen at Jocil and the rest, with Below Average growth at Mahickra Chem., Arvee Laborat., Indian Phosphate, Vital Chemtech, Hindcon Chemical, Par Drugs & Che., Paragon Fine, Ushanti Colour, and Nilachal Carbo. Capital Structure ratings are Excellent for Jocil, Indian Phosphate, Par Drugs & Che., and Paragon Fine, Good for Arvee Laborat., Hindcon Chemical, and Nilachal Carbo, while Below Average is found at Mahickra Chem., Vital Chemtech, Ushanti Colour, and Indian Emuls.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mahickra Chem. at 88.37%, while the lowest is Indian Emuls at -73.32%. Jocil's own 1-year return is -10.23%, which is higher than Indian Emuls but lower than Mahickra Chem. Additionally, Hindcon Chemical, Par Drugs & Che., and Indian Emuls have negative six-month returns.

What does Jocil do?

Jocil Ltd, a subsidiary of Andhra Sugars Limited, manufactures chemical products like Stearic Acid and Fatty Acids, with a market cap of INR 137 Cr and reported net sales of 265 Cr and net profit of 3 Cr for the quarter ending March 2026. The company operates in the Chemicals & Petrochemicals industry and is classified as a Micro Cap.

Overview:<BR>Jocil Ltd is engaged in the manufacture of various chemical products including Stearic Acid, Fatty Acids, and Industrial Oxygen, operating within the Chemicals & Petrochemicals industry and classified as a Micro Cap company.<BR><BR>History:<BR>Incorporated in 1978, Jocil Ltd is a subsidiary of Andhra Sugars Limited. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 265 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 3 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 137 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 16.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.32% <BR>Debt-Equity: -0.04 <BR>Return on Equity: 3.95% <BR>Price to Book: 0.65 <BR><BR>Contact Details:<BR>Address: Dokiparru, Guntur Andhra Pradesh: 522438 <BR>Tel: 91-0863-2290190 <BR>Email: jocil@jocil.com <BR>Website: http://www.jocil.in

Should I buy, sell or hold Jocil Ltd?

Are Jocil Ltd latest results good or bad?

Jocil Ltd's latest Q4 FY26 results show a significant net profit increase of 65.82% quarter-on-quarter and 482.22% year-on-year, alongside modest revenue growth. However, concerns remain due to low profitability metrics and historical performance, suggesting a mixed outlook despite positive market reaction.

Jocil Ltd's latest results for Q4 FY26 show a mixed picture. On one hand, the company reported a significant increase in net profit, which rose by 65.82% quarter-on-quarter and an impressive 482.22% year-on-year, reaching ₹2.62 crore. Revenue also grew, albeit modestly, by 0.97% quarter-on-quarter and 48.90% year-on-year, totaling ₹265.26 crore. Furthermore, the operating margin improved to 1.76%, the highest in seven quarters, indicating better operational efficiency.<BR><BR>However, despite these positive quarterly results, there are underlying concerns. The company's profitability metrics remain significantly below historical levels, and its return on equity (ROE) and return on capital employed (ROCE) are alarmingly low, at 2.85% and 0.66%, respectively. This suggests that while there has been a recent operational turnaround, the long-term performance and efficiency of the company are still in question.<BR><BR>The stock market reacted positively to the results, gaining 8.78% on the day of the announcement, reflecting investor optimism about the potential for recovery. Nevertheless, the overall long-term performance remains mixed, with valuation concerns persisting. Investors should be cautious and monitor whether the recent improvements can be sustained over the coming quarters.

Is Jocil overvalued or undervalued?

As of November 3, 2025, Jocil is considered overvalued with a PE ratio of 70.49 and an EV to EBIT of 62.69, significantly higher than its peers, and has underperformed the Sensex with a return of -24.41% over the past year.

As of 3 November 2025, Jocil's valuation grade has moved from very expensive to expensive, indicating a slight improvement but still reflecting a high valuation relative to its fundamentals. The company is currently considered overvalued, supported by a PE ratio of 70.49, an EV to EBIT of 62.69, and a PEG ratio of 6.78, all of which are significantly higher than industry norms.<BR><BR>In comparison to its peers, Jocil's PE ratio is notably higher than Godrej Industries, which has a PE of 37.65 and is classified as attractive, and Deepak Nitrite, which is also expensive at a PE of 38.97. Additionally, Jocil's EV to EBITDA ratio of 12.61 is elevated compared to Godrej Industries' 29.75, further emphasizing its overvaluation. Recent stock performance shows Jocil underperforming against the Sensex over the year, with a return of -24.41% compared to the Sensex's 6.00%, reinforcing the notion that the stock may be overvalued in the current market environment.

How has been the historical performance of Jocil?

Jocil's historical performance shows fluctuating sales, with net sales rising to 865.54 Cr in Mar'25 but declining profitability, as profit after tax fell to 1.02 Cr from 1.73 Cr in Mar'24. Total assets increased to 287.67 Cr, but cash flow from operations decreased to 10.00 Cr in Mar'25.

Answer:<BR>The historical performance of Jocil shows fluctuating trends in key financial metrics over the years.<BR><BR>Breakdown:<BR>Jocil's net sales increased from 753.20 Cr in Mar'24 to 865.54 Cr in Mar'25, following a dip to 753.59 Cr in Mar'22 and a peak of 919.28 Cr in Mar'23. Total operating income mirrored this trend, rising to 865.54 Cr in Mar'25 from 753.20 Cr in Mar'24. However, total expenditure also increased to 860.25 Cr in Mar'25 from 748.08 Cr in Mar'24, leading to an operating profit (PBDIT) of 7.24 Cr in Mar'25, down from 9.08 Cr in Mar'24. Profit before tax similarly declined to 1.34 Cr in Mar'25 from 2.65 Cr in Mar'24, resulting in a profit after tax of 1.02 Cr in Mar'25, compared to 1.73 Cr in Mar'24. The company's earnings per share (EPS) dropped to 1.15 in Mar'25 from 1.95 in Mar'24. On the balance sheet, total assets rose to 287.67 Cr in Mar'25 from 278.70 Cr in Mar'24, while total liabilities also increased to 287.67 Cr in Mar'25 from 278.70 Cr in Mar'24. Cash flow from operating activities decreased to 10.00 Cr in Mar'25 from 16.00 Cr in Mar'24, with a net cash inflow of 0.00 Cr in Mar'25, unchanged from the previous year. Overall, Jocil's financial performance reflects a mix of growth in sales and assets, but challenges in profitability and cash flow management.

Who are the top shareholders of the Jocil?

The top shareholder of Jocil is The Andhra Sugars Limited, holding 55.02% of the shares. Ashok Jain is the largest public shareholder with 3.74%, while individual investors collectively own 35.01%.

The top shareholders of Jocil include The Andhra Sugars Limited, which holds a significant 55.02% of the shares, making it the largest promoter. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is Ashok Jain, with a holding of 3.74%. Additionally, individual investors collectively hold 35.01% of the shares.

What is the technical trend for Jocil?

As of May 12, 2025, Jocil's technical trend is mildly bearish, with mixed signals from various indicators, including a mildly bullish weekly MACD and bearish monthly MACD, alongside mildly bearish daily moving averages and Bollinger Bands.

As of 12 May 2025, the technical trend for Jocil has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The daily moving averages are mildly bearish, contributing to the overall mildly bearish sentiment. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly chart. KST reflects a mildly bullish trend weekly and bearish monthly. The Dow Theory indicates a mildly bearish trend on the weekly timeframe with no trend on the monthly. Overall, the indicators suggest a mildly bearish stance with some mixed signals, particularly in the weekly timeframe.

When is the next results date for Jocil?

No Upcoming Board Meetings

What is the bonus history of the Jocil?

Jocil Ltd has a bonus history that includes a 1:1 bonus issue announced on September 27, 2011, with a record date of September 28, 2011, meaning shareholders received an additional share for each share held.

Jocil Ltd has a bonus history that includes a 1:1 bonus issue announced with an ex-date of September 27, 2011. The record date for this bonus was September 28, 2011. This means that for every share held, shareholders received an additional share. If you have any more questions about Jocil or its financial activities, feel free to ask!

Has Jocil declared dividend?

Yes, Jocil has declared a dividend of 15% (₹1.5 per share) with an ex-date of September 6, 2024. While the dividend yield is 0.92%, total returns over various periods show mixed performance, with significant negative price returns in most periods, except for a positive total return of 6.05% over the last 5 years.

Jocil has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 06 Sep 24<BR><BR>Dividend Yield: 0.92%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -17.8%, with no dividend return, resulting in a total return of -17.8%.<BR><BR>Over the past year, the price return was -8.71%, with a dividend return of 0.79%, leading to a total return of -7.92%.<BR><BR>In the 2-year period, the price return was -13.77%, with a dividend return of 2.09%, resulting in a total return of -11.68%.<BR><BR>For the 3-year period, the price return was -13.02%, with a dividend return of 3.97%, leading to a total return of -9.05%.<BR><BR>In the last 4 years, the price return was -15.17%, with a dividend return of 4.75%, resulting in a total return of -10.42%.<BR><BR>Over the 5-year period, the price return was -1.91%, with a dividend return of 7.96%, leading to a total return of 6.05%.<BR><BR>Overall, while Jocil has declared a dividend, the total returns over various periods indicate a mixed performance, with significant negative price returns in most periods, although there is a positive total return over the 5-year period.